Dow Jones

40,211.72

0.53%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

RYZB

RayzeBio (RYZB)

RayzeBio Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RYZB

1

Fecha	Hora	Fuente	Título	Símbolo	Compañía
07/03/2024	15:07	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:RYZB	RayzeBio Inc
27/02/2024	15:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RYZB	RayzeBio Inc
26/02/2024	08:20	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:RYZB	RayzeBio Inc
26/02/2024	08:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RYZB	RayzeBio Inc
23/02/2024	06:53	Edgar (US Regulatory)	Form SC 14D9/A - Solicitation, recommendation statements: [Amend]	NASDAQ:RYZB	RayzeBio Inc
23/02/2024	05:59	Business Wire	Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer	NASDAQ:RYZB	RayzeBio Inc
12/02/2024	05:59	Business Wire	Bristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting Period	NASDAQ:RYZB	RayzeBio Inc
25/01/2024	07:53	Edgar (US Regulatory)	Form SC 14D9 - Solicitation, recommendation statements	NASDAQ:RYZB	RayzeBio Inc
08/01/2024	09:06	PR Newswire (US)	Kuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to Contact Law Firm	NASDAQ:RYZB	RayzeBio Inc
27/12/2023	15:15	Edgar (US Regulatory)	Form SC14D9C - Written communication relating to third party tender offer	NASDAQ:RYZB	RayzeBio Inc
26/12/2023	09:28	Dow Jones News	Trending: Bristol Myers Squibb to Buy RayzeBio	NASDAQ:RYZB	RayzeBio Inc
26/12/2023	07:04	Dow Jones News	RayzeBio Shares Soar Premarket on Takeover by Bristol Myers	NASDAQ:RYZB	RayzeBio Inc
26/12/2023	06:46	Dow Jones News	Bristol Myers Squibb to Buy RayzeBio for $4.1 Billion	NASDAQ:RYZB	RayzeBio Inc
26/12/2023	06:13	GlobeNewswire Inc.	Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio	NASDAQ:RYZB	RayzeBio Inc
26/12/2023	05:59	Business Wire	Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio	NASDAQ:RYZB	RayzeBio Inc
13/11/2023	15:04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RYZB	RayzeBio Inc
13/11/2023	15:01	GlobeNewswire Inc.	RayzeBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:RYZB	RayzeBio Inc
06/11/2023	15:05	GlobeNewswire Inc.	RayzeBio to Participate in Upcoming Investor Conferences in November 2023	NASDAQ:RYZB	RayzeBio Inc
01/11/2023	05:00	GlobeNewswire Inc.	RayzeBio Appoints Industry Leader Tim Van Hauwermeiren to Its Board of Directors	NASDAQ:RYZB	RayzeBio Inc
24/10/2023	07:00	GlobeNewswire Inc.	FDA selects RayzeBio to Participate in the Inaugural CDRP Program to Expedite Commercial Manufacturing Readiness for RYZ101 in GEP-NETs	NASDAQ:RYZB	RayzeBio Inc
18/10/2023	06:00	GlobeNewswire Inc.	RayzeBio to Present at European Society for Medical Oncology (ESMO) Congress	NASDAQ:RYZB	RayzeBio Inc
19/09/2023	17:51	KR Market News	인스타카트, 나스닥 데뷔로 주가는 12% 상승	NASDAQ:RYZB	RayzeBio Inc
19/09/2023	15:01	Business Wire	RayzeBio, Inc. Announces Closing of Upsized $358 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares	NASDAQ:RYZB	RayzeBio Inc